Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Fnu Aakash,Savanah D Gisriel,Amer M Zeidan,John M Bennett,Rafael Bejar,Jan Philipp Bewersdorf,Uma M Borate,Jacqueline Boultwood,Andrew M Brunner,Rena Buckstein,Hetty E Carraway,Jane E Churpek,Naval G Daver,Amy E DeZern,Fabio Efficace,Pierre Fenaux,Maria E Figueroa,Guillermo Garcia-Manero,Steven D Gore,Peter L Greenberg,Elizabeth A Griffiths,Stephanie Halene,Christopher S Hourigan,Tae Kon Kim,Nina Kim,Rami S Komrokji,Vijay K Kutchroo,Alan F List,Richard F Little,Ravindra Majeti,Aziz Nazha,Stephen D Nimer,Olatoyosi Odenike,Eric Padron,Mrinal M Patnaik,Uwe Platzbecker,Matteo G Della Porta,Gail J Roboz,David A Sallman,Valeria Santini,Guillermo Sanz,Michael R Savona,Mikkael A Sekeres,Maximilian Stahl,Daniel T Starczynowski,David P Steensma,Justin Taylor,Omar Abdel-Wahab,Andrew H Wei,Zhuoer Xie,Mina L Xu,Robert P Hasserjian,Sanam Loghavi
DOI: https://doi.org/10.1016/j.modpat.2024.100615
2024-09-23
Abstract:Myelodysplastic neoplasms/syndromes (MDS) are a heterogeneous group of biologically distinct entities characterized by variable degrees of ineffective hematopoiesis. Recently, 2 classification systems (the 5th edition of the World Health Organization Classification of Haematolymphoid tTumours and the International Consensus Classification) further subcharacterized MDS into morphologically and genetically defined groups. Accurate diagnosis and subclassification of MDS require a multistep systemic approach. The International Consortium for MDS (icMDS) summarizes a contemporary, practical, and multimodal approach to MDS diagnosis and classification.